Therapy-induced senescence in breast cancer: an overview
Exploration of Targeted Anti-tumor Therapy · 25.07.2024 · 5 (4) · 902-920
DOI: 10.37349/etat.2024.00254 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Exploration of Targeted Anti-tumor Therapy, online erschienen am 25.07.2024. Verfasst von Suraj Narayanan Chembukavu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Membrane Trafficking and Disease Laboratory, School of Biochemistry & Cell Biology, Biosciences Institute, University College Cork, Cork, T12 YT20, I…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Outcomes for women with breast cancer have improved dramatically in recent decades. However, many patients present with intrinsic drug resistance and others are initially sensitive to anti-cancer drugs but acquire resistance during the course of their treatment, leading to recurrence and/or metastasis. Drug therapy-induced senescence (TIS) is a form of drug resistance characterised by the induction of cell cycle arrest and the emergence of a senescence-associated secretory phenotype (SASP) that can develop in response to chemo- and targeted- therapies. A wide range of anticancer interventions can lead to cell cycle arrest and SASP induction, by inducing genotoxic stress, hyperactivation of signalling pathways or oxidative stress. TIS can be anti-tumorigenic in the short-term, but pro-tumorigenic in the long-term by creating a pro-inflammatory and immunosuppressive microenvironment. Moreover, the SASP can promote angiogenesis and epithelial-mesenchymal transition in neighbouring cells. In this review, we will describe the characteristics of TIS in breast cancer and detail the changes in phenotype that accompany its induction. We also discuss strategies for targeting senescent cancer cells in order to prevent or delay tumour recurrence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Membrane Trafficking and Disease Laboratory, School of Biochemistry & Cell Biology, Biosciences Institute, University College Cork, Cork, T12 YT20, Ireland.
ORCID-Profile: Suraj Narayanan Chembukavu, Andrew J Lindsay
Zitieren
APA
Chembukavu, S. N., & Lindsay, A. J. (2024). Therapy-induced senescence in breast cancer: an overview. Exploration of Targeted Anti-tumor Therapy, 5(4), 902-920. https://doi.org/10.37349/etat.2024.00254
Vancouver
Chembukavu SN, Lindsay AJ. Therapy-induced senescence in breast cancer: an overview. Exploration of Targeted Anti-tumor Therapy. 2024;5(4):902-920. doi:10.37349/etat.2024.00254
BibTeX
@article{Chembukavu2024,
author = {Chembukavu, Suraj Narayanan and Lindsay, Andrew J},
title = {Therapy-induced senescence in breast cancer: an overview},
journal = {Exploration of Targeted Anti-tumor Therapy},
year = {2024},
volume = {5},
number = {4},
pages = {902--920},
doi = {10.37349/etat.2024.00254}
}
EUVIMED